Ambev (ABEV) Competitors $2.29 +0.04 (+1.78%) As of 04/14/2025 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABEV vs. BUD, DEO, KDP, CCU, COCO, WEST, BRCC, WVVI, BLNE, and IBGShould you be buying Ambev stock or one of its competitors? The main competitors of Ambev include Anheuser-Busch InBev SA/NV (BUD), Diageo (DEO), Keurig Dr Pepper (KDP), Compañía Cervecerías Unidas (CCU), Vita Coco (COCO), Westrock Coffee (WEST), BRC (BRCC), Willamette Valley Vineyards (WVVI), Eastside Distilling (BLNE), and Innovation Beverage Group (IBG). These companies are all part of the "beer & liquor" industry. Ambev vs. Anheuser-Busch InBev SA/NV Diageo Keurig Dr Pepper Compañía Cervecerías Unidas Vita Coco Westrock Coffee BRC Willamette Valley Vineyards Eastside Distilling Innovation Beverage Group Anheuser-Busch InBev SA/NV (NYSE:BUD) and Ambev (NYSE:ABEV) are both large-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations, community ranking and institutional ownership. Is BUD or ABEV more profitable? Ambev has a net margin of 17.02% compared to Anheuser-Busch InBev SA/NV's net margin of 10.98%. Ambev's return on equity of 16.12% beat Anheuser-Busch InBev SA/NV's return on equity.Company Net Margins Return on Equity Return on Assets Anheuser-Busch InBev SA/NV10.98% 15.29% 6.47% Ambev 17.02%16.12%10.48% Is BUD or ABEV a better dividend stock? Anheuser-Busch InBev SA/NV pays an annual dividend of $0.77 per share and has a dividend yield of 1.2%. Ambev pays an annual dividend of $0.09 per share and has a dividend yield of 3.9%. Anheuser-Busch InBev SA/NV pays out 26.5% of its earnings in the form of a dividend. Ambev pays out 52.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Does the MarketBeat Community believe in BUD or ABEV? Anheuser-Busch InBev SA/NV received 347 more outperform votes than Ambev when rated by MarketBeat users. Likewise, 65.42% of users gave Anheuser-Busch InBev SA/NV an outperform vote while only 60.73% of users gave Ambev an outperform vote. CompanyUnderperformOutperformAnheuser-Busch InBev SA/NVOutperform Votes73265.42% Underperform Votes38734.58% AmbevOutperform Votes38560.73% Underperform Votes24939.27% Which has better valuation and earnings, BUD or ABEV? Anheuser-Busch InBev SA/NV has higher earnings, but lower revenue than Ambev. Ambev is trading at a lower price-to-earnings ratio than Anheuser-Busch InBev SA/NV, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnheuser-Busch InBev SA/NV$59.77B1.91$5.34B$2.9121.79Ambev$89.45B0.40$2.90B$0.1713.47 Does the media favor BUD or ABEV? In the previous week, Ambev had 3 more articles in the media than Anheuser-Busch InBev SA/NV. MarketBeat recorded 12 mentions for Ambev and 9 mentions for Anheuser-Busch InBev SA/NV. Anheuser-Busch InBev SA/NV's average media sentiment score of 1.59 beat Ambev's score of 0.48 indicating that Anheuser-Busch InBev SA/NV is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anheuser-Busch InBev SA/NV 8 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Ambev 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, BUD or ABEV? Anheuser-Busch InBev SA/NV has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Comparatively, Ambev has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Do analysts recommend BUD or ABEV? Anheuser-Busch InBev SA/NV currently has a consensus price target of $66.00, suggesting a potential upside of 4.10%. Ambev has a consensus price target of $2.45, suggesting a potential upside of 6.99%. Given Ambev's higher probable upside, analysts clearly believe Ambev is more favorable than Anheuser-Busch InBev SA/NV.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anheuser-Busch InBev SA/NV 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.11Ambev 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals & insiders have more ownership in BUD or ABEV? 5.5% of Anheuser-Busch InBev SA/NV shares are owned by institutional investors. Comparatively, 8.1% of Ambev shares are owned by institutional investors. 4.5% of Anheuser-Busch InBev SA/NV shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryAnheuser-Busch InBev SA/NV beats Ambev on 13 of the 21 factors compared between the two stocks. Remove Ads Get Ambev News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABEV vs. The Competition Export to ExcelMetricAmbevBeverages IndustryStaples SectorNYSE ExchangeMarket Cap$36.08B$54.50B$17.22B$18.59BDividend Yield4.03%2.64%3.04%4.25%P/E Ratio12.7217.3815.4931.16Price / Sales0.4024.003.3326.51Price / Cash6.9821.9616.3917.54Price / Book2.255.046.344.30Net Income$2.90B$2.61B$737.42M$1.02B7 Day Performance3.85%5.63%2.35%4.42%1 Month Performance-0.65%-9.57%-4.82%-6.62%1 Year Performance-2.55%-14.00%-1.54%0.15% Ambev Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABEVAmbev1.3092 of 5 stars$2.29+1.8%$2.45+7.0%-2.6%$36.08B$89.45B12.7252,000BUDAnheuser-Busch InBev SA/NV1.7441 of 5 stars$59.34-2.6%$66.00+11.2%+8.1%$106.65B$59.77B18.31166,600News CoveragePositive NewsHigh Trading VolumeDEODiageo2.4083 of 5 stars$102.75-1.2%$129.00+25.6%-19.3%$57.12B$20.21B14.9928,600Short Interest ↓Positive NewsGap DownKDPKeurig Dr Pepper3.4643 of 5 stars$33.800.0%$38.38+13.6%+18.2%$46.05B$15.35B20.5728,000Positive NewsCCUCompañía Cervecerías Unidas1.3095 of 5 stars$13.89-5.4%$11.03-20.6%+23.7%$2.57B$2.90T18.529,350Short Interest ↓COCOVita Coco1.9431 of 5 stars$29.20+4.5%$34.57+18.4%+25.4%$1.66B$516.01M29.44280WESTWestrock Coffee2.3728 of 5 stars$6.14-3.2%$10.50+71.0%-40.9%$578.00M$850.73M-7.131,399Short Interest ↑BRCCBRC1.7381 of 5 stars$2.01+0.3%$4.60+129.4%-49.6%$427.15M$391.49M-25.06840Gap DownWVVIWillamette Valley Vineyards0.2755 of 5 stars$5.90-2.5%N/A+30.3%$29.29M$39.78M-9.67270Analyst ForecastGap DownBLNEEastside DistillingN/A$1.62-4.7%N/AN/A$11.69M$9.54M-0.4470News CoverageGap UpIBGInnovation Beverage GroupN/A$0.78-1.6%N/AN/A$6.49M$3.15M0.00N/ANews CoverageGap Down Remove Ads Related Companies and Tools Related Companies BUD Alternatives DEO Alternatives KDP Alternatives CCU Alternatives COCO Alternatives WEST Alternatives BRCC Alternatives WVVI Alternatives BLNE Alternatives IBG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ABEV) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ambev S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ambev With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.